Home > Journals > Biology and research > European Cytokine Network > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Biology and research
European Cytokine Network
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Clinical significance of matrix metalloproteinases activity in acute myocardial infarction


European Cytokine Network. Volume 16, Number 2, 152-60, June 2005, Research papers

Free Article  

Author(s) : DP Papadopoulos, I Moyssakis, TK Makris, M Poulakou, G Stavroulakis, D Perrea, VE Votteas

Summary : Matrix metalloproteinases (MMP) degrade myocardial fibrillar collagen in acute myocardial infarction (MI) patients. Their activity is tightly controlled in normal myocardium by a family of closely related tissue inhibitors known as TIMP. An imbalance in their activity might contribute to post-MI remodeling. Plasma levels of MMP-1, TIMP-1 and MMP-1/TIMP-1 complex were measured, using relevant ELISA kits, in 24 (22 males-2 females), acute MI patients with a mean age 59 ± 14 years. Blood samples were taken on admission (0h),and 3h, 6h, 9h, 18h, 24h, 36h, 48h, 3 rd, 4 th, 5 th, 7 th, 15  th, 30  th days after MI. All patients underwent coronary arteriography with ventriculography for estimation of left ventricular ejection fraction (LVEF) and extent of coronary artery diseases, and echocardiographic study for measuring end-diastolic diameter (EDD). Ten patients with an LVEF <\; 45%, an EDD > 47.5mm, and heart failure symptoms were included in group A and compared against 12 patients with an LVEF > 45% an EDD <\; 47.5mm in group B.Mean plasma concentrations of MMP-1 were higher by 21% in group A (1.3 ± 0.2 ng/mL) compared to group B (1 ± 0.1 ng/mL) over the total study period. TIMP-1 plasma concentrations showed very little difference between the 2 groups, (704 ± 213 ng/mL versus 691 ± 165 ng/mL, (6%)) Finally, plasma concentrations of MMP-1/TIMP-1 complex were lower by -36% in group A with a mean value of 2.7 ± 0.6 ng/mL versus 3.7 ± 0.5 ng/mL in group B. Mean values for the differences were significant at time points 0, 6, 18, 24 and 48 hours for MMP-1 (p <\; 0.036), and on 48h and the 4 th day for MMP-1/TIMP-1 complex (p <\; 0.031). Moreover, a good correlation was found between plasma concentrations of creatine kinase (CK) and MMP-1 at 18h (r \= 0.422, p \= 0.041) and on the 4 th day (r \= 0.67, p \= 0.046), and TIMP-1 on the 4 th day (r \= 0.67, p \= 0.047). Additionally, mean values for LVEF were 35.8 ± 8.8% in group A versus 51.2 ± 1.8% (p \= 0.00014) in group B. Also, the EDD in-group A was 52.1 ± 6.9 mm versus 42.9 ± 3.2 mm in group B (p \= 0.00013). In acute MI patients, increased MMP-1, with no change in TIMP-1, is associated with left ventricular dysfunction and dilatation, suggesting that increased collagenolytic activity contributes to loss of LV function.

Keywords : matrix metalloproteinases, acute myocardial infarction, extracellular matrix

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]